Adiponectin counteracts leptin protumor effects, suggesting that obesity-associated breast carcinogenesis is mainly regulated by a leptin–adiponectin axis imbalance [126]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.